Evaluation of the ability of colistin, amoxicillin (components of Potencil®), and fluoroquinolones to attenuate bacterial endotoxin‐ and Shiga exotoxin‐mediated cytotoxicity—In vitro studies. Issue 1 (15th September 2018)
- Record Type:
- Journal Article
- Title:
- Evaluation of the ability of colistin, amoxicillin (components of Potencil®), and fluoroquinolones to attenuate bacterial endotoxin‐ and Shiga exotoxin‐mediated cytotoxicity—In vitro studies. Issue 1 (15th September 2018)
- Main Title:
- Evaluation of the ability of colistin, amoxicillin (components of Potencil®), and fluoroquinolones to attenuate bacterial endotoxin‐ and Shiga exotoxin‐mediated cytotoxicity—In vitro studies
- Authors:
- Szuster‐Ciesielska, Agnieszka
Urban‐Chmiel, Renata
Wernicki, Andrzej
Mascaron, Laurent
Wasak, Marek
Bousquet, Eric - Abstract:
- Abstract: Escherichia coli is one of the major pathogens in humans and animals causing localized and systemic infections, which often lead to acute inflammation, watery diarrhea, and hemorrhagic colitis. Bacterial lipopolysaccharide (LPS) and Shiga exotoxins (Stx) are mostly responsible for such clinical signs. Therefore, highly effective treatment of E. coli infections should include both eradication of bacteria and neutralization of their toxins. Here, for the first time, we compared the in vitro ability of common antibiotics to decrease LPS‐ and Stx‐mediated cytotoxicity: colistin, amoxicillin (used separately or combined), enrofloxacin, and its metabolite ciprofloxacin. Three experimental scenarios were realized as follows: (a) the direct effect of antibiotics on endotoxin, (b) the effect of antibiotic treatment on LPS‐mediated cytotoxicity in an experiment mimicking "natural infection, " (c) the effect of antibiotics to decrease Stx2e‐mediated cytotoxicity. Two cell lines, A549 and Vero cells, were used to perform cytotoxic assays with the methyl tetrazolium (MTT) and lactate dehydrogenase leakage (LDH) methods, respectively. Colistin and amoxicillin, especially used in combination, were able to attenuate LPS toxic effect, which was reflected by increase in A549 cell viability. In comparison with other antibiotics, the combination of colistin and amoxicillin exhibited the highest boster or additive effect in protecting cells against LPS‐ and Stx2e‐induced toxicity. InAbstract: Escherichia coli is one of the major pathogens in humans and animals causing localized and systemic infections, which often lead to acute inflammation, watery diarrhea, and hemorrhagic colitis. Bacterial lipopolysaccharide (LPS) and Shiga exotoxins (Stx) are mostly responsible for such clinical signs. Therefore, highly effective treatment of E. coli infections should include both eradication of bacteria and neutralization of their toxins. Here, for the first time, we compared the in vitro ability of common antibiotics to decrease LPS‐ and Stx‐mediated cytotoxicity: colistin, amoxicillin (used separately or combined), enrofloxacin, and its metabolite ciprofloxacin. Three experimental scenarios were realized as follows: (a) the direct effect of antibiotics on endotoxin, (b) the effect of antibiotic treatment on LPS‐mediated cytotoxicity in an experiment mimicking "natural infection, " (c) the effect of antibiotics to decrease Stx2e‐mediated cytotoxicity. Two cell lines, A549 and Vero cells, were used to perform cytotoxic assays with the methyl tetrazolium (MTT) and lactate dehydrogenase leakage (LDH) methods, respectively. Colistin and amoxicillin, especially used in combination, were able to attenuate LPS toxic effect, which was reflected by increase in A549 cell viability. In comparison with other antibiotics, the combination of colistin and amoxicillin exhibited the highest boster or additive effect in protecting cells against LPS‐ and Stx2e‐induced toxicity. In summary, in comparison with fluoroquinolones, the combination of colistin and amoxicillin at concentrations similar to those achieved in plasma of treated animals exhibited the highest ability to attenuate LPS‐ and Stx2e‐mediated cytotoxicity. … (more)
- Is Part Of:
- Journal of veterinary pharmacology and therapeutics. Volume 42:Issue 1(2019)
- Journal:
- Journal of veterinary pharmacology and therapeutics
- Issue:
- Volume 42:Issue 1(2019)
- Issue Display:
- Volume 42, Issue 1 (2019)
- Year:
- 2019
- Volume:
- 42
- Issue:
- 1
- Issue Sort Value:
- 2019-0042-0001-0000
- Page Start:
- 85
- Page End:
- 103
- Publication Date:
- 2018-09-15
- Subjects:
- amoxicillin -- colistin -- fluoroquinolones -- lipopolysaccharide -- Shiga exotoxins
Veterinary pharmacology -- Periodicals
Therapeutics -- Periodicals
636.0895105 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2885 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jvp.12710 ↗
- Languages:
- English
- ISSNs:
- 0140-7783
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5072.420000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9617.xml